The use of abatacept did not lead to significant improvements in the disease status of patients with primary Sjögren's syndrome and in fact, it was essentially no better than placebo treatment, shows the first randomized, double-blind trial on abatacept for Sjögren’s.
French researchers identified a specific phenotype along with predictive factors.
Test your clinical acumen with this 5-question quiz.
Fish oil supplements proved no better than placebo at relieving dry eye disease.
Find out how much you know about one of the most difficult chronic autoimmune disorders to manage.